Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Lung Cancer Surgery Equipment Market Expected To Become By 2029 Compared With Its 2025 Level?
The lung cancer surgery equipment market size has demonstrated robust expansion in recent years. It is forecast to grow from $3.49 billion in 2024 to $3.73 billion in 2025, at a compound annual growth rate (CAGR) of 6.7%. The surge in the historic period can be attributed to the rising prevalence of smoking, increasing early diagnosis rates, improved surgical survival outcomes, higher adoption of lobectomy procedures, government cancer screening programs, growing hospital infrastructure, availability of skilled thoracic surgeons, a rise in open thoracotomy surgeries, limited alternatives to surgery, and reimbursement support for cancer surgeries.
The lung cancer surgery equipment market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $4.79 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.5%. This projected growth is driven by several factors, including an increased occurrence of lung cancer among non-smokers, the expanding global elderly demographic, the broadening scope of minimally invasive surgical techniques, a heightened need for robotic-assisted thoracic procedures, greater expenditure on healthcare, better outcomes in post-surgical recovery, an increase in outpatient thoracic interventions, supportive regulatory endorsements, heightened public understanding via lung cancer campaigns, and expanding insurance penetration in developing economies. Key trends anticipated during this period encompass the implementation of robotic-assisted surgical platforms, the application of AI in surgical preparation, the incorporation of 3D imaging into operations, the creation of more compact thoracoscopic instruments, upgraded visualization technologies, the proliferation of remote surgical methods, live intraoperative guidance, the deployment of intelligent staplers and devices, custom surgical tools produced through 3D printing, and AI-powered post-operative monitoring solutions.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24594&type=smp
What Are The Main Drivers Boosting The Lung Cancer Surgery Equipment Industry’s Expansion?
The increasing occurrence of lung cancer is anticipated to boost the expansion of the lung cancer surgery equipment market moving forward. Lung cancer is defined by the unrestrained proliferation of atypical cells within the lungs, frequently attributed to smoking or exposure to detrimental environmental factors. The surge in lung cancer incidents is primarily linked to heightened exposure to risk elements such as tobacco smoke, airborne pollutants, and workplace carcinogens, coupled with a demographic shift towards an older population. Lung cancer surgery equipment plays a crucial role in diagnosing the condition, excising malignant tissue, and facilitating post-operative recovery via accurate surgical procedures and continuous patient observation. As an illustration, the Cancer Council, an Australia-based non-profit organization, reported in February 2025 that an estimated 15,122 individuals in Australia were diagnosed with lung cancer in 2024, with the mean age at diagnosis being 72. In Australia, lung cancer stands as the fifth most prevalent cancer diagnosis, and it is projected that roughly one in 20 Australians will receive this diagnosis by the time they reach 85 years old. Consequently, the expanding incidence of lung cancer is propelling the advancement of the lung cancer surgery equipment market.
How Is The Lung Cancer Surgery Equipment Market Segmented?
The lung cancer surgery equipment market covered in this report is segmented –
1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment
2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery
3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation
4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes
Subsegments:
1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures
2) By Access Devices: Trocars, Catheters, Guidewires, Introducers
3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices
4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems
5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices
6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors
How Are Emerging Market Trends Shaping The Lung Cancer Surgery Equipment Industry Landscape?
Major companies in the lung cancer surgery equipment market are concentrating on developing devices for robotically assisted bronchoscopy to enhance the precision and safety of tumor localization and biopsy, improve access to hard-to-reach lung nodules, and support early and accurate diagnosis of lung cancer. Robotically assisted bronchoscopy is an advanced medical procedure that utilizes robotic technology to guide a bronchoscope, a thin, flexible tube, into the lungs with greater precision and control than traditional manual techniques. For example, in March 2025, Johnson and Johnson, a US-based pharmaceutical company, announced that its MONARCH QUEST system, an advanced robotic-assisted bronchoscopy technology, had received U.S. FDA 510(k) clearance. This system represents the latest evolution of the MONARCH Platform, designed to improve the diagnosis of lung cancer through minimally invasive procedures. The system interfaces with the GE HealthCare OEC 3D mobile CBCT Imaging System, allowing for real-time, intraprocedural 3D imaging. This integration improves the precision of targeting lung nodules, especially those located in hard-to-reach areas of the lung.
Which Major Industry Participants Are Leading The Lung Cancer Surgery Equipment Market Growth?
Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc., Boston Scientific Corporation, Zimmer Biomet Inc., Olympus Corporation, Intuitive Surgical Inc., Teleflex Incorporated, KARL STORZ GmbH & Co. KG, Integra LifeSciences Corporation, Elekta AB, Accuray Incorporated, Richard Wolf GmbH, Angiodynamics Inc., B. Braun Melsungen AG, Quantum Surgical SAS, Sontec Instruments Inc., Novadaq Technologies Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-equipment-global-market-report
Which Regional Markets Are Contributing Most To The Lung Cancer Surgery Equipment Industry Expansion?
North America was the largest region in the lung cancer surgery equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Lung Cancer Surgery Equipment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24594&type=smp
Browse Through More Reports Similar to the Global Lung Cancer Surgery Equipment Market 2025, By The Business Research Company
Lung Cancer Diagnostic And Screening Global Market Report 2025
Lung Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report
Thoracic Surgery Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/thoracic-surgery-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
